Zacks Investment Research | Jun 21, 2019 08:43AM ET
Hologic, Inc. (NASDAQ:HOLX) has recently made a binding offer to acquire (directly or through an affiliate) SuperSonic Imagine — a France-based innovator in cart-based ultrasound products. Also, the company announced that it has signed an exclusive negotiation deal with SuperSonic Imagine and its primary shareholders.
The acquisition is in sync with the company’s strategy to provide wide-ranging screening, interventional and surgical solutions across the spectrum of breast health care.
Financial Terms
Under the terms of the binding offer, Hologic has agreed to acquire SuperSonic Imagine’s outstanding shares at €1.50 per share. This corresponds to all outstanding shares of approximately $39 million (or $42 million assuming dilution of all outstanding warrants and options). Further, Moreover, Hologic will generate funds to repay SuperSonic Imagine’s net debt of $43 million. Summing up, this equates to a maximum enterprise value of $85 million.
About the Acquisition
Through the acquisition of SuperSonic Imagine, the company is likely to foray into the $450-million cart-based global breast ultrasound market, which is expanding at a high-single-digit rate. The upside can be attributed to the technology being adopted as an adjunct to mammography in women with dense breast tissue. SuperSonic Imagine’s product portfolio will strengthen the utility of Viera, the wireless, handheld ultrasound scanner that Hologic is commercializing through a development and distribution agreement with Clarius Mobile Health.
Market Prospects
Per Zacks Investment Research
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.